267 related articles for article (PubMed ID: 17476279)
1. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
[TBL] [Abstract][Full Text] [Related]
3. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
4. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
[TBL] [Abstract][Full Text] [Related]
5. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
[TBL] [Abstract][Full Text] [Related]
6. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
Gündüz E; Demirel G; Bal C; Gulbas Z
Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
Ran D; Schubert M; Taubert I; Eckstein V; Bellos F; Jauch A; Chen H; Bruckner T; Saffrich R; Wuchter P; Ho AD
Exp Hematol; 2012 Feb; 40(2):155-65.e1. PubMed ID: 22024109
[TBL] [Abstract][Full Text] [Related]
9. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
10. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
12. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
13. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
[TBL] [Abstract][Full Text] [Related]
14. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
15. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
16. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
[TBL] [Abstract][Full Text] [Related]
17. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.
Storms RW; Green PD; Safford KM; Niedzwiecki D; Cogle CR; Colvin OM; Chao NJ; Rice HE; Smith CA
Blood; 2005 Jul; 106(1):95-102. PubMed ID: 15790790
[TBL] [Abstract][Full Text] [Related]
18. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.
Lioznov MV; Freiberger P; Kröger N; Zander AR; Fehse B
Bone Marrow Transplant; 2005 May; 35(9):909-14. PubMed ID: 15765109
[TBL] [Abstract][Full Text] [Related]
20. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
